These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 15809508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study.
    Hutchison AJ, Maes B, Vanwalleghem J, Asmus G, Mohamed E, Schmieder R, Backs W, Jamar R, Vosskühler A.
    Nephron Clin Pract; 2006; 102(2):c61-71. PubMed ID: 16224198
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
    Shigematsu T, Lanthanum Carbonate Group.
    Clin Nephrol; 2008 Nov; 70(5):404-10. PubMed ID: 19000540
    [Abstract] [Full Text] [Related]

  • 6. One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis.
    Shigematsu T, Lanthanum Carbonate Research Group.
    Ther Apher Dial; 2010 Feb; 14(1):12-9. PubMed ID: 20438515
    [Abstract] [Full Text] [Related]

  • 7. The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.
    Soriano S, Ojeda R, Rodríguez M, Almadén Y, Rodríguez M, Martín-Malo A, Aljama P.
    Clin Nephrol; 2013 Jul; 80(1):17-22. PubMed ID: 23391319
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
    Zhai CJ, Yang XW, Sun J, Wang R.
    Int Urol Nephrol; 2015 Mar; 47(3):527-35. PubMed ID: 25399356
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T, LANDMARK Investigators and Committees.
    JAMA; 2021 May 18; 325(19):1946-1954. PubMed ID: 34003226
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.
    Ohtake T, Kobayashi S, Oka M, Furuya R, Iwagami M, Tsutsumi D, Mochida Y, Maesato K, Ishioka K, Moriya H, Hidaka S.
    J Cardiovasc Pharmacol Ther; 2013 Sep 18; 18(5):439-46. PubMed ID: 23615577
    [Abstract] [Full Text] [Related]

  • 19. Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.
    Hutchison AJ, Laville M, SPD405-313 Lanthanum Study Group.
    Nephrol Dial Transplant; 2008 Nov 18; 23(11):3677-84. PubMed ID: 18577536
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of lanthanum carbonate in German patients on dialysis.
    Dellanna F, Reichel H, Seibt F.
    Clin Nephrol; 2012 Nov 18; 78(5):382-90. PubMed ID: 22948119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.